{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2024:X5CBKB5JWSAKLKEU2V2RPUHERJ","short_pith_number":"pith:X5CBKB5J","schema_version":"1.0","canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","source":{"kind":"arxiv","id":"2404.12827","version":3},"attestation_state":"computed","paper":{"title":"An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"cs.CL","authors_text":"Alban Bornet, Anthony Yazdani, Boya Zhang, Douglas Teodoro, Hossein Rouhizadeh, Philipp Khlebnikov, Poorya Amini","submitted_at":"2024-04-19T12:04:32Z","abstract_excerpt":"Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments. CT-ADE encompasses 2,497 drugs and 168,984 drug-ADE pairs from clinical trial results, annotated using the MedDRA ontology. Unlike existing resources, CT-ADE integrates treatment and target population data, enabling comparative analyses under varying conditions, such as dosage, administration route, and demographics. In "},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2404.12827","kind":"arxiv","version":3},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CL","submitted_at":"2024-04-19T12:04:32Z","cross_cats_sorted":[],"title_canon_sha256":"f3f35d21982d49a1860e75473ad2a9ada38524affb182d4ee94cb177e90b7965","abstract_canon_sha256":"d57d84e8b39a51a755bd919552ea8987e938bd7bee5be79576ec0153b5cd476a"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T10:27:09.469496Z","signature_b64":"rib5ZzEcD6bwNvLj9VmmujwPAHFiZ3cJk0mYW4YctyYbLFgpZ2yPkS5p+8s2hb5lhQantNFZhvNOoh2KY5rCBQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","last_reissued_at":"2026-07-05T10:27:09.468963Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T10:27:09.468963Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"cs.CL","authors_text":"Alban Bornet, Anthony Yazdani, Boya Zhang, Douglas Teodoro, Hossein Rouhizadeh, Philipp Khlebnikov, Poorya Amini","submitted_at":"2024-04-19T12:04:32Z","abstract_excerpt":"Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments. CT-ADE encompasses 2,497 drugs and 168,984 drug-ADE pairs from clinical trial results, annotated using the MedDRA ontology. Unlike existing resources, CT-ADE integrates treatment and target population data, enabling comparative analyses under varying conditions, such as dosage, administration route, and demographics. In "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2404.12827","kind":"arxiv","version":3},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2404.12827/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2404.12827","created_at":"2026-07-05T10:27:09.469027+00:00"},{"alias_kind":"arxiv_version","alias_value":"2404.12827v3","created_at":"2026-07-05T10:27:09.469027+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2404.12827","created_at":"2026-07-05T10:27:09.469027+00:00"},{"alias_kind":"pith_short_12","alias_value":"X5CBKB5JWSAK","created_at":"2026-07-05T10:27:09.469027+00:00"},{"alias_kind":"pith_short_16","alias_value":"X5CBKB5JWSAKLKEU","created_at":"2026-07-05T10:27:09.469027+00:00"},{"alias_kind":"pith_short_8","alias_value":"X5CBKB5J","created_at":"2026-07-05T10:27:09.469027+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ","json":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ.json","graph_json":"https://pith.science/api/pith-number/X5CBKB5JWSAKLKEU2V2RPUHERJ/graph.json","events_json":"https://pith.science/api/pith-number/X5CBKB5JWSAKLKEU2V2RPUHERJ/events.json","paper":"https://pith.science/paper/X5CBKB5J"},"agent_actions":{"view_html":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ","download_json":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ.json","view_paper":"https://pith.science/paper/X5CBKB5J","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2404.12827&json=true","fetch_graph":"https://pith.science/api/pith-number/X5CBKB5JWSAKLKEU2V2RPUHERJ/graph.json","fetch_events":"https://pith.science/api/pith-number/X5CBKB5JWSAKLKEU2V2RPUHERJ/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/action/timestamp_anchor","attest_storage":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/action/storage_attestation","attest_author":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/action/author_attestation","sign_citation":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/action/citation_signature","submit_replication":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/action/replication_record"}},"created_at":"2026-07-05T10:27:09.469027+00:00","updated_at":"2026-07-05T10:27:09.469027+00:00"}